Biomarker Technologies Market(2020-203), Trends and Forecast till 2023

Biomarker Technologies Market Information: By Product (Consumables, Instruments), by Profiling Technology (PCR, Imaging Technology, NGS), by Disease Application (Cancer, Infectious Disease), Research Area (Genomics, Proteomics) – Global Forecast Till 2023

According to Market Research Future (MRFR), the global biomarker technologies market share is expected to reach USD 78 billion, with a CAGR of 9% from 2017 to 2023 (forecast period). 

The term biomarker is generally used to define a measurable indicator of a biological state or condition. The term also refers to a substance whose detection indicates the presence of a living organism. In medicine, a biomarker is referred to as a traceable material that is introduced into an organism to test the proper functioning of any organ. In cell biology, a biomarker is used as a medium for the detection of cellular defects, and for the isolation of a specific cell type (for example, Oct-4 protein is used as a biomarker for the identification of embryonic stem cells). In genetics, a biomarker or genetic marker is a stretch of the DNA sequence or oligonucleotide sequence that can be used to create genetic maps of any organism being studied. Biomarkers are used for diagnosis and clinical decision-making in cancer, diabetes, cardiovascular and neurological diseases. 

Market Dynamics

The market for biomarker technologies is rising exponentially under the influence of increased incidences of cancer, diabetes, cardiovascular and neurological diseases. Moreover, developments in the field of medical technology, government initiatives to promote research in the field of biomarker technologies, and an increase in the use of biomarkers to improve the accuracy of disease diagnosis are expected to spur market growth.

Market Segmentation

The global biomarker technologies market is segmented based on product type, profiling technology, disease application, and research areas. 

Based on product type, the global biomarker technologies market is divided into consumables, instruments, services, and software/informatics.

Based on profiling technology, the global biomarker technologies market is segmented into imaging technology, immunoassay, PCR, NGS, chromatography, cytogenetics, mass spectrometry, and other technologies. The immunoassay segment is further segmented into ELISA, western blot, and protein microarray.

Based on disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

Based on research areas, the global market for biomarker technologies is segmented into metabolomics genomics, Proteomics, and other research areas. The metabolomics segment is further segmented into lipidomic and others.

Regional Analysis

Regionally, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. 

The Americas are expected to account for the largest share of the market in biomarker technologies. The growing prevalence of cancer, cardiovascular disorders, neurological and autoimmune diseases and an increasing geriatric population are likely to propel the growth of the biomarker technologies market. For example, the National Cancer Institute (NCI) reported that there were 1,666,540 new cases of cancer in the United States in 2014. As a result, this increasing patient pool is expected to accelerate market growth during the forecast period. In addition, factors such as growing government initiatives and funding for research, the development of advanced medical treatment options, and the availability of favorable refund policies are likely to fuel the growth of the biomarker technology market in the American region. In addition, according to CMS (Centers for Medicare and Medicaid Services) U.S. health care spending risen by 4.3% to reach USD 3.3 trillion per person in 2016. As a result, rising personal per capita incomes and increasing health care spending, are likely to help boost America's market growth.

Europe is the second-largest market leader and holds a healthy share of the global market for biomarker technologies. The European market is expected to have a robust growth rate during the forecast period due to the availability of extensive treatment facilities and established healthcare infrastructure, along with a growing need for an effective and accurate diagnosis. According to Cancer Research UK, around 9,921 cases were diagnosed in 2015. These increasing incidences of cancer are expected to have a substantial impact on the market for biomarker technologies due to its widespread use in cancer. This impact would boost the biomarker technologies market in Europe.

The Asia Pacific is anticipated to be the fastest emerging market in the world. Factors such as the growing prevalence of chronic diseases are the key drivers of market development. For example, as per the International Diabetes Federation, almost 382 million people worldwide had diabetes in 2013. It is expected to reach around 500 million by the end of 2035. China and India are the first and second most affected diabetes nations. Increasing numbers of diabetic patients may lead to an increase in the number of patients with cardiovascular disease. As a result, these countries are anticipated to be the fastest-growing regions due to an increasing patient pool, health awareness, and the availability of new treatment methods. Moreover, increasing healthcare expenditure and growing living standards in the region are fueling the growth of the biomarker technologies market in the Asia Pacific region.

The Middle East and Africa are expected to report the least growth in the market due to some key factors such as lack of awareness and limited access and availability of treatment facilities. Throughout the Middle East, the United Arab Emirates is the largest market due to the growth of the healthcare sector and the growing availability of specialty care centers. With an increasing number of infectious diseases in the country, several key players are eager to set up their research and development centers to find a cure for these diseases. This will boost the use of biomarkers and, as a result, a steady growth rate could be seen during the forecast period.

Key Players

Some of the significant participants in the global biomarker technologies market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Roche, Waters Corporation, Danaher Corporation, Shimadzu Corporation, Danaher Corporation, Siemens Healthcare.

Read More @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Latest Updates : Biomarker Technologies Market Size, Growth 2020 and Forecast to 2023

Biomarker Technologies Market Insights

Market Research Future has announced its new research report on the global biomarker technologies stating that the market is probable to rise at a CAGR of 9% till the year 2023. The reports also mention that the market is all set to gain a valuation of USD 78 Billion in the years to come, which is a sign of positive impact of the market on global level. The report takes in account the parts such as regional, type, and application segmentation of the global biomarker technologies, which portrays the market status among all these categories. 

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6150

The biomarker is defined as a measurable indicator of some biological state or condition. The term is also referred as a solid substance that detects and indicates the presence of a living organism. In medicine, a biomarker traces to examine proper functioning of any organ, whereas in cell biology, a biomarker is used for the detection of cellular defects and isolation of a cell type. And in genetics, a biomarker is a stretch of DNA sequence that can be used to create genetic maps for any organism. Even for diagnosis and clinical decision making, biomarkers are referred especially for cancer, diabetes, cardiovascular, and neurological diseases. These features of biomarkers are predominantly encouraging the global biomarker technologies to expand exponentially in the years to come. 

Global Biomarker Technologies: Drivers & Trends

The global biomarker technologies market is expanding globally under various factors such as   increased incidences of diseases—cancer, diabetes, cardiovascular, and neurological diseases, advances in medical technologies, governmental initiatives supporting research in biomarker technologies, and growing use of biomarkers to increase the accuracy of disease diagnosis. 

Currently, the most important applications of biomarkers are in discovery and development of drug. Here, the role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described in well version. Biomarkers, thus, facilitates the combination of therapeutics with diagnostics and plays an important role in the development of personalized medicine. These factors are also influencing the global biomarker technologies market to expand tremendously during the forecast period. 

Apart from this, the growth of the global biomarker technologies market is mainly driven by more factors such as increasing healthcare expenditure and increasing research & developing funding. It has been observed, that the swelling utility of biomarkers in diagnostic process and new initiatives for biomarker research, all are aiding for the growth of the market. Nevertheless, the requirement of high capital investments for the discovery, development, and validation of biomarkers are somehow restraining the growth of the biomarker technologies market.

Also, on the flip side, factor of high cost of biomarkers are restricting the growth of the biomarker technologies market.

Market Segmentation

According to MRFR, the global biomarker technologies market has been segmented based on product type, profiling technology, disease application, and research areas.

By the product type, the market is segmented into consumables, instruments, services, and software/informatics.

By profiling technology type, the market is segmented into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies. 

By immunoassay, the market is again segmented into ELISA, western blot, and protein microarray.

By disease application, the market is categorized as cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

By research areas, the market is segmented into Genomics, Proteomics, Metabolomics, and other research areas. Metabolomics is further segmented into lipidomic and others.

Regional Outlook

On a geographical note, the global biomarker technologies market has covered main regions of Americas, Europe, Asia Pacific, and the Middle East and Africa. 

Among these, Americas is going to account for the largest share of the biomarker technologies market owing to the increasing prevalence of cancer, cardiovascular diseases, neurological as well as autoimmune diseases, and rising geriatric population. These factors are likely to enhance the growth of the biomarker technologies market. Also, the increasing patient pool is likely to enhance the market growth during the forecast period. Moreover, the increasing government initiatives and funding for research, development in advanced medical treatment options, and availability of favorable reimbursement policies are likely to propel the growth of the biomarker technologies market in the American region. 

While, Europe is the second market leader and holds a healthy share in the global biomarker technologies market and is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities and established healthcare infrastructure along with growing need for efficient and accurate diagnosis.

Whereas, Asia Pacific is expected to be the fastest emerging market owing to the increasing prevalence of chronic diseases is the major driver for the market growth. China and India are the first and second most affected countries with diabetes. The increasing number of diabetic patients can lead to the increasing patient number with cardiovascular diseases. Thus, these countries are expected to be the fastest growing regions due to the increasing patient pool, raising awareness about health, and availability of new treatment methods. 

The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the development of the healthcare industry and rising availability of specialty care centers. With the increasing number of epidemic diseases in this region, many key players are willing to set up their research and development centers to find a cure for these diseases. This will increase the usage of biomarkers and thus, a steady growth rate might be seen during the forecast period.

Market Players

MRFR has listed some of the most active market players contributing to the market to expand, they are: Abbott Laboratories

• Agilent Technologies
• Thermo Fisher Scientific
• Roche
• Waters Corporation
• Danaher Corporation
• Shimadzu Corporation
• Danaher Corporation
• Siemens Healthcare

Read Complete Report @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Analysis and Regional Demand on Biomarker Technologies Market Forecast to 2023

According to Market Research Future (MRFR), the global biomarker technologies market share is expected to reach USD 78 billion, with a CAGR of 9% from 2017 to 2023 (forecast period). 

The term biomarker is generally used to define a measurable indicator of a biological state or condition. The term also refers to a substance whose detection indicates the presence of a living organism. In medicine, a biomarker is referred to as a traceable material that is introduced into an organism to test the proper functioning of any organ. In cell biology, a biomarker is used as a medium for the detection of cellular defects, and for the isolation of a specific cell type (for example, Oct-4 protein is used as a biomarker for the identification of embryonic stem cells). In genetics, a biomarker or genetic marker is a stretch of the DNA sequence or oligonucleotide sequence that can be used to create genetic maps of any organism being studied. Biomarkers are used for diagnosis and clinical decision-making in cancer, diabetes, cardiovascular and neurological diseases. 

Market Dynamics

The market for biomarker technologies is rising exponentially under the influence of increased incidences of cancer, diabetes, cardiovascular and neurological diseases. Moreover, developments in the field of medical technology, government initiatives to promote research in the field of biomarker technologies, and an increase in the use of biomarkers to improve the accuracy of disease diagnosis are expected to spur market growth.

Market Segmentation

The global biomarker technologies market is segmented based on product type, profiling technology, disease application, and research areas. 

Based on product type, the global biomarker technologies market is divided into consumables, instruments, services, and software/informatics.

Based on profiling technology, the global biomarker technologies market is segmented into imaging technology, immunoassay, PCR, NGS, chromatography, cytogenetics, mass spectrometry, and other technologies. The immunoassay segment is further segmented into ELISA, western blot, and protein microarray.

Based on disease application, the market is segmented into cancer, infectious disease, autoimmune diseases, neurological, cardiovascular disorders, and other disorders.

Based on research areas, the global market for biomarker technologies is segmented into metabolomics genomics, Proteomics, and other research areas. The metabolomics segment is further segmented into lipidomic and others.

Regional Analysis

Regionally, the market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. 

The Americas are expected to account for the largest share of the market in biomarker technologies. The growing prevalence of cancer, cardiovascular disorders, neurological and autoimmune diseases and an increasing geriatric population are likely to propel the growth of the biomarker technologies market. For example, the National Cancer Institute (NCI) reported that there were 1,666,540 new cases of cancer in the United States in 2014. As a result, this increasing patient pool is expected to accelerate market growth during the forecast period. In addition, factors such as growing government initiatives and funding for research, the development of advanced medical treatment options, and the availability of favorable refund policies are likely to fuel the growth of the biomarker technology market in the American region. In addition, according to CMS (Centers for Medicare and Medicaid Services) U.S. health care spending risen by 4.3% to reach USD 3.3 trillion per person in 2016. As a result, rising personal per capita incomes and increasing health care spending, are likely to help boost America's market growth.

Europe is the second-largest market leader and holds a healthy share of the global market for biomarker technologies. The European market is expected to have a robust growth rate during the forecast period due to the availability of extensive treatment facilities and established healthcare infrastructure, along with a growing need for an effective and accurate diagnosis. According to Cancer Research UK, around 9,921 cases were diagnosed in 2015. These increasing incidences of cancer are expected to have a substantial impact on the market for biomarker technologies due to its widespread use in cancer. This impact would boost the biomarker technologies market in Europe.

The Asia Pacific is anticipated to be the fastest emerging market in the world. Factors such as the growing prevalence of chronic diseases are the key drivers of market development. For example, as per the International Diabetes Federation, almost 382 million people worldwide had diabetes in 2013. It is expected to reach around 500 million by the end of 2035. China and India are the first and second most affected diabetes nations. Increasing numbers of diabetic patients may lead to an increase in the number of patients with cardiovascular disease. As a result, these countries are anticipated to be the fastest-growing regions due to an increasing patient pool, health awareness, and the availability of new treatment methods. Moreover, increasing healthcare expenditure and growing living standards in the region are fueling the growth of the biomarker technologies market in the Asia Pacific region.

The Middle East and Africa are expected to report the least growth in the market due to some key factors such as lack of awareness and limited access and availability of treatment facilities. Throughout the Middle East, the United Arab Emirates is the largest market due to the growth of the healthcare sector and the growing availability of specialty care centers. With an increasing number of infectious diseases in the country, several key players are eager to set up their research and development centers to find a cure for these diseases. This will boost the use of biomarkers and, as a result, a steady growth rate could be seen during the forecast period.

Key Players

Some of the significant participants in the global biomarker technologies market are Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Roche, Waters Corporation, Danaher Corporation, Shimadzu Corporation, Danaher Corporation, Siemens Healthcare.

Read More @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Biomarker Technologies Market Industry Status, Key Regions, Application, Top Key Players, Future and Forecast Till 2025

Biomarker Technologies Market Information: By Product (Consumables, Instruments), by Profiling Technology (PCR, Imaging Technology, NGS), by Disease Application (Cancer, Infectious Disease), Research Area (Genomics, Proteomics) – Global Forecast Till 2023

Market Insights 

Biomarkers have a broad spectrum of clinical uses and in medicine. It is critical in both diagnostics and ascertaining the best treatment route. Largely used for cancer, biomarkers and biomarker technology market is growing in use and is experiencing increasing demand. Market Research Future has performed a detailed study on the market and all its factors to ascertain that the market is likely to witness a CAGR of 99% during the forecast period of 2018 to 2023 and reach an estimated USD 78 bn by the end of the review period. 

Biomarkers are effective for various medical applications besides diagnosis. They can be helpful in disease prevention, drug target identification, and several others. The growing global prevalence of  chronic diseases, neurological disorders & diseases, and cardiovascular diseases; these are the result of growing urbanization, and changing global environment. The high demand for biomarker technologies is driven primarily by the advancement of medical technologies, and the growing investments in healthcare and medical sectors across the world. Moreover, governments and the associated government health, medicine, & drug bodies are highly supportive of biomarkers and biomarker technologies research and development. The increasing use of biomarkers in an effort to produce accurate diagnoses is additionally expected to support market growth over the assessment period. 

The high capital investments required for the development of biomarkers and discovery of the same combined with the high cost of the use of biomarker technology is expected to restrain market growth. However, growing research and advancement in the field has brought biomarker technology a long way and is expected to contribute significantly to a wide scope for future growth.

Market Segmentation

MRfR's segmental assessment has been performed on the basis of product type, profiling technology, disease application, research areas, and region. By product type, the market is segmented into instruments, consumables, services, and software/informatics.

Based on profiling technology, the market is segmented into PCR, imaging technology, immunoassay, mass spectrometry, chromatography, NGS, cytogenetics, and other technologies. Further sub-segments are available for immunoassay in the report. 

By disease application, the market is segmented into infection diseases, neurological, cardiovascular disorders, autoimmune diseases, cancer, and other disorders. 

Based on research areas, the market is segmented into proteomics, metabolomics, genomics, and other research areas. Metabolomics is sub-segmented to include lipidomic and others.

Regional Analysis

The global biomarker technologies market is analyzed globally and divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Led by North America, the Americas account for the largest share of the global biomarker technologies market.  There are a high prevalence of cancer, diabetes, cardiovascular, neurological, and autoimmune diseases which have led to a skyrocket in demand for effective diagnostic and treatment technologies. Moreover, the presence of steadily rising geriatric population , increased initiatives from the government, increasing funding for research and the growing availability of favorable reimbursement policies is expected to drive demand, and development of the technology. High growth is expected from the region in the coming years as health care spending has risen and the availability of ample opportunities for growth.

Meanwhile, the Asia-Pacific is projected to witness rapid growth at the highest CAGR, globally. The presence of a massive population pool, with growing incidences of chronic diseases, has proven to be a significant driver of growth. China and India are two of the most highly affected countries with a high diabetic population. These countries are fast emerging markets, due to the highly supportive government policies surrounding healthcare, increased funding for investment, and health care and the growing, rising disposable income which has led to increased healthcare spending by patients.

Key Players

MRFR's analysis of the competitive landscape of the market reveals several key players that are driving the market with their research & development, patent filing and use of other market driving strategies. Prominent market players include Waters Corporation, Danaher Corporation, Shimadzu Corporation, Seimens Healthcare, Bio-Rad Laboratories, and Abbott Laboratories among others.

Latest Industry News

Immunexpress has received a Notice of US Patent Allowance for its patent application for "validating biomarker measurement." This is part of its SeptiCyte technology and is expected to prove useful in the diagnosis of sepsis.

The European Medicines Agency (EMA), has provided a positive qualification opinion regarding the use of biomarkers as a vital tool to increase clinical trials on Parkinsons Disease. The biomarker tool in this purpose would assist trials by providing measurements which allow medical professionals to choose people most suitable for Parkinson's clinical trials.

QIAGEN N.V has partnered with multiple organizations to support the set up of a global genomics campus in Manchester U.K. to promote innovation and research of molecular diagnostics.

Read more @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Biomarker Technologies Market Demand, Key Players, Industry Overview and Future Forecasts to 2023

The biomarker technologies industry is growing pervasively at the rapid pace; mainly due to the increased research and development activities that are driven by substantial investments.  Simultaneously, the rising demand for diagnosis and treatment of diseases associated with the old age escalates the market growth on the global platform. 

Acknowledging the accruals, the market is garnering currently, Market Research Future (MRFR) in its recently published study report, asserts that the growth of the global biomarker technologies will reach USD 78 BN by 2023, registering a staggering CAGR of 9 % from 2018 to 2023.  

Additional factors fostering the market growth include the widened uptake of biomarkers technologies, increasing research and development activities transpired into the field of biomarker test, growing number of contract research organizations and the cost-effective clinical trials. The spreading awareness towards the effective diagnosis processes along with the growing demand for personalized medicine is contributing to the market growth to an extent. 

On the other hand, high capital investments required for the discovery, development of biomarkers, and the high cost of biomarkers are some of the factors obstructing the market growth. Nevertheless, government grants and initiatives that are undertaken to increase the R&D activities in the field are expected to support the market growth. 

Biomarker Technologies Market   - Segmentation 

The MRFR analysis is segmented into five key dynamics for the convenience of understanding; 

By Product Types : Consumables, Instruments, Services, and Software/Informatics among others. 

By Profiling Technologies :  Immunoassay (ELISA, western blot, and protein microarray.), PCR, Imaging Technology, Mass Spectrometry, NGS, Chromatography, and Cytogenetics, among other Technologies.

By Disease Applications : Cancer, Infectious Disease, Autoimmune Diseases, Neurological, and Cardiovascular Disorders, among other disorders.

By Research Areas : Genomics, Proteomics, and Metabolomics (lipidomic and others.), among other research areas.

By Regions : Europe, North America, APAC and the Rest-of-the-World.

Biomarker Technologies Market   - Regional Analysis

The North American region dominates the global biomarker technology market. Heading with the rapid research and development initiatives, the market is expected to create a large revenue pocket over the forecast period. Factors substantiating the market growth include substantial investments in the R&D activities in the field of diagnosis, prognostic treatments, and drug formulation. 

Furthermore, the increasing prevalence of cancer, cardiovascular, autoimmune and neurological diseases alongside the rising geriatric population are positively impacting the market growth in the region. Additional factors such as high healthcare expenditures, increasing government initiatives and funding for research, development to discover advanced medical treatment options, and the availability of favorable reimbursement policies are expected to propel the market growth in the region.

Europe accounts for the second-largest market for biomarker technologies. With the availability of advanced treatment facilities and established healthcare infrastructure and the growing demand for accurate diagnosis, the market is expected to register a considerable CAGR. Besides, factors such as favorable governmental support and initiatives propel the market growth in the region.

The proliferating healthcare sector heading with the resurging economy is fostering the market growth brilliantly. The rising incidences of cancer are expected to impact on the biomarker technologies market positively. 

Whereas, the Asia Pacific biomarker technologies market is proliferating, emerging as one of the promising markets, globally. Asian countries especially, India and China provide immense growth opportunities for the biomarker technologies market, accounting for the huge population.  Additionally, factors such as the increasing prevalence of chronic diseases are the major driving forces for the market growth. 

Furthermore, factors such as the increasing patient pool, raising awareness about healthcare, and the availability of new treatment methods are fostering the market growth in the region. Also, rising healthcare expenditure and improvement in the standard of living due to the improving economic conditions in the region are propelling the growth of biomarker technologies market in the APAC. 

Biomarker Technologies Market   - Competitive Analysis 

Highly competitive biomarker technologies market appears to be fragmented. Major players are focusing on optimizing situational awareness towards customers to ensure their mission success. Matured players are increasingly seeking market expansion through various strategic activities such as M&A, innovation, increasing investments in R&D and cost-effective product portfolio. 

Key Players:

The market leaders profiled in the MRFR analysis include Abbott Laboratories, Agilent Technologies, Thermo Fisher Scientific, Roche Waters Corporation, Danaher Corporation, Shimadzu Corporation, Danaher Corporation, and Siemens Healthcare. 

Industry/Innovation/Related News:

November 01, 2018 – Sirona Dx (US), a leader in high-complexity genomics and proteomics services, introduced Imaging Mass Cytometry™ services on the Fluidigm Hyperion™ Imaging System to advance biomarker discovery and therapeutic development.

Considering the impressive Imaging Mass Cytometry results from top pharmaceutical companies and leading academic medical centers, Sirona Dx had taken this decision to bring some more biomarker technologies into the field. 

October 29, 2018 – NanoString Technologies, Inc. (US), a provider of life science tools for translational research and molecular diagnostic products, announced signing a translational research agreement with NanoString Technologies, Inc. (US), a leading provider of life science tools for translational research and molecular diagnostic products to identify and develop biomarkers for MacroGenics’ MGD013 program.

Read More @ https://www.marketresearchfuture.com/reports/biomarker-technologies-market-6150 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com